# EDGAR Filing Document

**Accession Number:** 0002017651
**File Stem:** 0002035625-25-000004
**Filing Date:** 2025-8
**Character Count:** 1521
**Document Hash:** ba1358fe3d5b4bf36dd54f2d75ecf9c9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0002035625-25-000004.hdr.sgml**: 20250813

**ACCESSION NUMBER**: 0002035625-25-000004

**CONFORMED SUBMISSION TYPE**: C-W

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250813

**DATE AS OF CHANGE**: 20250813

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Sarcomatrix Therapeutics Corp
- **CENTRAL INDEX KEY:** 0002017651

**ORGANIZATION NAME:**
- **EIN:** 882525253
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** C-W
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 020-34981
- **FILM NUMBER:** 251210530

**BUSINESS ADDRESS:**
- **STREET 1:** 450 SINCLAIR ST
- **CITY:** RENO
- **STATE:** NV
- **ZIP:** 89501
- **BUSINESS PHONE:** 415-246-3311

**MAIL ADDRESS:**
- **STREET 1:** 450 SINCLAIR ST
- **CITY:** RENO
- **STATE:** NV
- **ZIP:** 89501

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM C

### UNDER THE SECURITIES ACT OF 1933

### Issuer Information

**Name of Issuer:** Sarcomatrix Therapeutics Corp

**Is there a Co-Issuer?:** No

### Signatures

**Issuer:** Sarcomatrix Therapeutics Corp

**Signature:** David Craig

**Title:** CEO

---

**Signature:** David Craig

**Title:** CEO

**Date:** 08-13-2025

---

**Signature:** Ryan David Wuebbles

**Title:** CSO

**Date:** 08-13-2025

---

**Signature:** Dean Josef Burkin

**Title:** Board Member

**Date:** 08-13-2025

---

**Signature:** Michael J.M. Hitchcock

**Title:** Board Member

**Date:** 08-13-2025